Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 187

1.

Long-term treatment of anxiety disorders with pregabalin: a 1 year open-label study of safety and tolerability.

Montgomery S, Emir B, Haswell H, Prieto R.

Curr Med Res Opin. 2013 Oct;29(10):1223-30. doi: 10.1185/03007995.2013.820694. Epub 2013 Aug 19.

PMID:
23808960
3.

A randomized, double-blind, placebo-controlled, fixed-dose, multicenter study of pregabalin in patients with generalized anxiety disorder.

Feltner DE, Crockatt JG, Dubovsky SJ, Cohn CK, Shrivastava RK, Targum SD, Liu-Dumaw M, Carter CM, Pande AC.

J Clin Psychopharmacol. 2003 Jun;23(3):240-9.

PMID:
12826986
4.

Long-term efficacy of pregabalin in generalized anxiety disorder.

Feltner D, Wittchen HU, Kavoussi R, Brock J, Baldinetti F, Pande AC.

Int Clin Psychopharmacol. 2008 Jan;23(1):18-28.

PMID:
18090504
5.

Duloxetine: a review of its use in the treatment of generalized anxiety disorder.

Carter NJ, McCormack PL.

CNS Drugs. 2009;23(6):523-41. doi: 10.2165/00023210-200923060-00006. Review.

PMID:
19480470
6.

Efficacy and tolerability of pregabalin using a flexible, optimized dose schedule in Korean patients with peripheral neuropathic pain: a 10-week, randomized, double-blind, placebo-controlled, multicenter study.

Moon DE, Lee DI, Lee SC, Song SO, Yoon DM, Yoon MH, Kim HK, Lee YW, Kim C, Lee PB.

Clin Ther. 2010 Dec;32(14):2370-85. doi: 10.1016/j.clinthera.2011.01.014.

PMID:
21353106
7.

Pregabalin for treatment of generalized anxiety disorder: a 4-week, multicenter, double-blind, placebo-controlled trial of pregabalin and alprazolam.

Rickels K, Pollack MH, Feltner DE, Lydiard RB, Zimbroff DL, Bielski RJ, Tobias K, Brock JD, Zornberg GL, Pande AC.

Arch Gen Psychiatry. 2005 Sep;62(9):1022-30.

PMID:
16143734
8.

Safety and efficacy of two pregabalin regimens for add-on treatment of partial epilepsy.

Beydoun A, Uthman BM, Kugler AR, Greiner MJ, Knapp LE, Garofalo EA; Pregabalin 1008-009 Study Group.

Neurology. 2005 Feb 8;64(3):475-80.

PMID:
15699378
9.

Efficacy of pregabalin in generalized social anxiety disorder: results of a double-blind, placebo-controlled, fixed-dose study.

Feltner DE, Liu-Dumaw M, Schweizer E, Bielski R.

Int Clin Psychopharmacol. 2011 Jul;26(4):213-20. doi: 10.1097/YIC.0b013e32834519bd.

PMID:
21368587
10.

Efficacy and safety of pregabalin in elderly people with generalised anxiety disorder.

Montgomery S, Chatamra K, Pauer L, Whalen E, Baldinetti F.

Br J Psychiatry. 2008 Nov;193(5):389-94. doi: 10.1192/bjp.bp.107.037788.

11.

Long-term add-on pregabalin treatment in patients with partial-onset epilepsy: pooled analysis of open-label clinical trials.

Uthman BM, Bazil CW, Beydoun A, Schulze-Bonhage A, Benabou R, Whalen E, Emir B, Griesing T, Leon T.

Epilepsia. 2010 Jun;51(6):968-78. doi: 10.1111/j.1528-1167.2010.02532.x. Epub 2010 Mar 19.

12.

Does early improvement predict endpoint response in patients with generalized anxiety disorder (GAD) treated with pregabalin or venlafaxine XR?

Baldwin DS, Schweizer E, Xu Y, Lyndon G.

Eur Neuropsychopharmacol. 2012 Feb;22(2):137-42. doi: 10.1016/j.euroneuro.2011.07.005. Epub 2011 Aug 11.

PMID:
21839620
13.

[Efficacy and tolerability of escitalopram in anxiety disorders: a review].

Pelissolo A.

Encephale. 2008 Sep;34(4):400-8. doi: 10.1016/j.encep.2008.04.004. Epub 2008 Aug 15. Review. French.

PMID:
18922243
14.

How well do randomized controlled trial data generalize to 'real-world' clinical practice settings? A comparison of two generalized anxiety disorder studies.

Kasper S, Brasser M, Schweizer E, Lyndon G, Prieto R.

Eur Neuropsychopharmacol. 2014 Jan;24(1):125-32. doi: 10.1016/j.euroneuro.2013.10.015. Epub 2013 Nov 11.

PMID:
24290532
15.

Efficacy and safety of duloxetine in the treatment of generalized anxiety disorder: a flexible-dose, progressive-titration, placebo-controlled trial.

Rynn M, Russell J, Erickson J, Detke MJ, Ball S, Dinkel J, Rickels K, Raskin J.

Depress Anxiety. 2008;25(3):182-9.

PMID:
17311303
16.
17.

Efficacy of pregabalin for peripheral neuropathic pain: results of an 8-week, flexible-dose, double-blind, placebo-controlled study conducted in China.

Guan Y, Ding X, Cheng Y, Fan D, Tan L, Wang Y, Zhao Z, Hong Z, Zhou D, Pan X, Chen S, Martin A, Tang H, Cui L.

Clin Ther. 2011 Feb;33(2):159-66. doi: 10.1016/j.clinthera.2011.02.007. Epub 2011 Mar 27.

PMID:
21444113
18.
19.

Pregabalin for the treatment of generalized anxiety disorder.

Wensel TM, Powe KW, Cates ME.

Ann Pharmacother. 2012 Mar;46(3):424-9. doi: 10.1345/aph.1Q405. Epub 2012 Mar 6. Review.

PMID:
22395254
20.

Supplemental Content

Support Center